Pfizer GLS 25 Pill - yellow round, 7mm
Generic Name: glasdegib
Pill with imprint Pfizer GLS 25 is Yellow, Round and has been identified as Daurismo 25 mg. It is supplied by Pfizer Inc.
Daurismo is used in the treatment of Acute Myeloid Leukemia and belongs to the drug class hedgehog pathway inhibitors. Daurismo 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer GLS 25
Daurismo
- Generic Name
- glasdegib
- Imprint
- Pfizer GLS 25
- Strength
- 25 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Hedgehog pathway inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0298
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Idarubicin
Idarubicin is used for acute myeloid leukemia, leukemia, leukocytoclastic vasculitis, solid tumors
Daunorubicin
Daunorubicin is used for acute lymphocytic leukemia, acute myeloid leukemia, acute nonlymphocytic ...
Midostaurin
Midostaurin is used for acute myeloid leukemia, systemic mastocytosis
Azacitidine
Azacitidine is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic myelogenous ...
More about Daurismo (glasdegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.